Medistim ASA
SWB:MD1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Medistim ASA
SWB:MD1
|
NO |
|
M
|
Mebuki Financial Group Inc
F:5EE
|
JP |
|
R
|
Radcom Ltd
SWB:RAM
|
IL |
|
Research Solutions Inc
F:61I
|
US |
|
S
|
STORE Capital Corp
F:S76
|
US |
|
Bitmine Immersion Technologies Inc
OTC:BMNR
|
US |
Wall St Price Targets
MD1 Price Targets Summary
Medistim ASA
According to Wall Street analysts, the average 1-year price target for MD1 is 27.94 EUR with a low forecast of 27.67 EUR and a high forecast of 28.76 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MD1's stock price target?
Price Target
27.94
EUR
According to Wall Street analysts, the average 1-year price target for MD1 is 27.94 EUR with a low forecast of 27.67 EUR and a high forecast of 28.76 EUR.
What is the Revenue forecast for Medistim ASA?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Medistim ASA?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Medistim ASA?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 3 years is 4%.
